Covered recipient · General Payments record
SHAHAB A KHAN
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$1,509.98
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $254.69 | 7 |
| Education | $3.08 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $110.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $48.92 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $30.93 | 1 |
| Retrophin, Inc. | $27.09 | 2 |
| Ardelyx, Inc. | $24.89 | 1 |
| Acerta Pharma LLC | $15.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $110.00 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117597320 | CMS |
| Ardelyx, Inc. | $24.89 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146689004 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.94 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105860590 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $30.93 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086161860 | CMS |
| Novartis Pharmaceuticals Corporation | $34.09 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087114564 | CMS |
| Novartis Pharmaceuticals Corporation | $14.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087114598 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 01/18/2024 | Education | Undisputed | 01/23/2026 | 1149930351 | CMS |
| Travere Therapeutics, Inc. | $24.01 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149930355 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.